Skip to content

Multimodal Prehabilitation Program for Women Undergoing Gynecologic Oncology Surgery

Role of Multimodal Prehabilitation Program in Improving Surgical Outcomes for Women Undergoing Gynecologic Oncology Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07188662
Enrollment
140
Registered
2025-09-23
Start date
2024-04-23
Completion date
2025-07-23
Last updated
2025-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic Oncology Patient

Brief summary

The goal of this clinical trial is to evaluate the role of multimodal Prehabilitation program on improve surgical outcomes after gynecological oncology surgery.

Detailed description

Multimodal prehabilitation program focused on improving woman physical and psychological wellbeing before gynecological oncology surgery. Multimodal prehabilitation refers to a combination of preoperative interventions targeting physical, nutritional, psychological, and medical optimization. This program included various element such preoperative physical exercise, nutritional support, psychological counselling, social support and education about surgical processes. Multimodal Prehabilitation programs play an important role in improving surgical outcomes after gynecological oncology surgery.

Interventions

PROCEDUREgroup (B) Prehabilitation care combine with ERAS post-operative care

intervention will includes receiving prehabilitation care combine with ERAS post-operative care.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Newly diagnosed woman with gynecologic cancer by imaging &histopathology * Accept participation in the study.

Exclusion criteria

* Patient with advanced and metastatic stage * Patient who received neoadjuvant chemotherapy * Patient who have psychological disorder such as suicidal attempt * Patient who have cerebral stroke, hemiplegia or paralyses

Design outcomes

Primary

MeasureTime frameDescription
changing the postoperative morbidityup to 30 days postoperativecompare the 30 days postoperative morbidity of the prehabilitation and conventional group, it included (Assess the post-operative complications by using Clavien-Dindo classification; from Grade I-IV; higher grades indicate more severe complications.)
changing the postoperative mortalityup to 30 days postoperativecompare the 30 days postoperative mortality of the prehabilitation group and conventional group.
Pain intensity measured by the Visual Analog Scale (VAS) for pain.up to 30 days postoperativecompare the 30 days postoperative Pain intensity; Unit of Measure: Units on a scale (0-10 cm). Scale: 0 = no pain, 10 = worst pain imaginable; higher scores indicate worse pain of the prehabilitation group and conventional group.

Secondary

MeasureTime frameDescription
assess and changing the Nutritional Status of the prehabilitation groupup-to 30 days postoperativeNutritional Status measured through the following: 1. Nutritional Status - Height/m Description: Patient height measured in meters. 2. Nutritional Status - Weight/kg Description: Patient body weight measured in kilograms. * weight and height combined to report BMI in kg/m\^2
change the length of the hospital stayup to 5 days post-operativecompare the days of the hospital stay between the prehabilitation group and conventional group to measure the effect of the intervention program in changing the length of hospital stays (Number of days from surgery until hospital discharge).
improve the Cardiopulmonary fitness of gynecological oncology patient after surgeryup-to 15 days preoperatively & up to 30 days post operatively]Cardiopulmonary Fitness measured by use of: 1- 6-Minute Walk Test (6MWT) Distance * Description: Distance walked in meters. * Time Frame: Up to 30 days post operatively .
Enhance the physical state of gynecological oncology patient using the Eastern Cooperative Oncology Group (ECOG)through the postoperative period within two hours up-to 30 days after surgery\- Eastern Cooperative Oncology Group (ECOG) is a performance method used to assess a cancer patient's level of functioning and ability to care for themselves, work, and carry out daily activities. ECOG Performance Status Scale included 5 grades from 0- 5 * Grade 0: Fully active, able to carry all activities without restriction. * Grade 1: Restricted in physically and able to do light work * Grade 2: Ambulatory and capable of self-care, but unable to carry out any work activities; up \>50% of waking hours. * Grade 3: Capable of only limited self-care; confined to bed or chair \>50% of waking hours. * Grade 4: Completely disabled; cannot carry on any self-care; totally confined to bed or chair. * Grade 5: Dead.
Enhance the psychological wellbeing of gynecological oncology patientup-to 15 days preoperatively & up to 30 days post operatively]\- measure the Psychological aspect by using DASS21(Depression, Anxiety, and Stress Scale - 21 items): . 1- Depression * Unit of Measure: Units on a scale (0-42). * Scale: Higher scores indicate worse depression. 2- Anxiety * Unit of Measure: Units on a scale (0-42). * Scale: Higher scores indicate worse anxiety. 3- Stress * Unit of Measure: Units on a scale (0-42). * Scale: Higher scores indicate worse stress

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026